CBY1 and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, Cby1 downmodulation complements BCR-ABL1-dependent events promoting beta catenin stabilization and nuclear import which provide LSC an advantage over the normal counterpart (Figure 6).